Strengthening Saudi-Singapore Biotech Collaboration! 🇸🇦🤝🇸🇬 Novo Genomics X AMILI

Novo Genomics X AMILI

Novo Genomics proudly announces its strategic partnership with AMILI to drive microbiome-based R&D in Saudi Arabia, contributing to the National Biotechnology Strategy. This collaboration will revolutionize precision nutrition, gut health, and personalized medicine, positioning the Kingdom as a leader in microbiome science.

We were honored to have HE Singapore Ambassador Mr. Premjith Sadasivan and Dr. Khalid Alburaikan, Biotech Advisor to HE Saudi Vice Minister of Health, at our launch event, highlighting the global importance of microbiome-driven health solutions.
Premjith Sadasivan
Khalid Alburikan
Jeremy Lim

🔬 Key Focus Areas:
✅ Establishing state-of-the-art microbiome research in Saudi Arabia
✅ Capacity building for local scientists in microbiome science
✅ Developing personalized health solutions using microbiome-based insights
✅ Advancing microbiome diagnostics and therapeutics

This is a major milestone in Saudi Arabia’s Vision 2030 and a leap forward in transforming healthcare through genomics and microbiome innovation! 🌍🔬